Nexium (Esomeprazole Magnesium Trihydrate)

Esomeprazole acts on the gastric proton pump pathway to reduce acid secretion in several acid‑related conditions.

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining.
• Erosive oesophagitis: facilitates ulcer healing and prevents recurrence.
• NSAID‑induced gastric ulcer: protects the gastric mucosa and supports ulcer resolution.
• Helicobacter pylori eradication (in combination therapy): enhances bacterial eradication rates when used with antibiotics.

• Esomeprazole magnesium trihydrate irreversibly binds to the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory surface of parietal cells, blocking the final step of gastric acid production. This inhibition leads to a sustained reduction in both basal and stimulated gastric acid secretion, allowing mucosal healing in acid‑related disorders.

Esomeprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Headache: mild to moderate pain often resolving without intervention.
• Diarrhea: loose stools that may be self‑limiting.
• Nausea: sensation of unease or urge to vomit.
• Abdominal pain: discomfort in the stomach area.
• Flatulence: increased intestinal gas.
• Constipation: difficulty passing stools.

Serious or Rare Side Effects

• Severe allergic reactions (anaphylaxis): swelling, rash, difficulty breathing.
• Clostridioides difficile infection: severe colitis with watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Liver enzyme elevation: signs of hepatic dysfunction.
• Stevens‑Johnson syndrome: skin blistering and mucosal involvement.
• Interstitial nephritis: kidney inflammation presenting with reduced urine output.

When prescribing or dispensing esomeprazole, consider the following precautions to ensure safe use.

• Assess renal function: adjust use in severe renal impairment.
• Avoid concomitant use with known CYP2C19 inhibitors unless medically necessary.
• Monitor for signs of infection: prolonged acid suppression may increase risk.
• Use with caution in patients with osteoporosis: long‑term use may affect calcium absorption.
• Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Esomeprazole can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect.
• Atazanavir: decreased absorption of atazanavir.
• Methotrexate (high dose): increased toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR.
• Digoxin: may increase serum levels.
• Diazepam: may increase plasma concentration.